FDA Inspection 1326098 — Conopco Inc. D/B/A Unilever
The FDA completed an inspection of Conopco Inc. D/B/A Unilever on Jul 13, 2026 in Raeford, NC. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 5 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jul 13, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Raeford, NC (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 1213 | 21 CFR 211.67(a) | Cleaning / Sanitizing / Maintenance |
| 1215 | 21 CFR 211.67(b) | Written procedures not established/followed |
| 1975 | 21 CFR 211.182 | Written records kept in individual logs |
| 3632 | 21 CFR 211.170(b) | Annual visual exams of drug products |